Fig. 2
From: VNTR polymorphism in the breakpoint region of ABL1 and susceptibility to bladder cancer
Allelic type patterns of ABL1-MS1 in cancer-free male controls and bladder cancer patients. a Haplotype patterns in cancer-free controls and cases with bladder cancer. The left panel is the haplotype pattern for ABL1-MS1 region from control samples. Three genotypes were identified consisting of two different ABL1-MS1 alleles. The right panel is the ABL1-MS1 haplotype pattern seen in bladder cancer patients, showing five genotypes consisting of four different ABL1-MS1 alleles. The first and last lanes correspond to a 100-bp (M1; Invitrogen Co., CA, USA) and a 1-kb size marker (M2; Invitrogen Co.). b Frequency of genotypes between controls and bladder cancer cases. N corresponds to the total number of samples tested for the allele of ABL1-MS1. C corresponds to the common alleles (13TR, 15TR) and indicates alleles with a frequency of 1% or more. Rare alleles (R) with a frequency of less than 1% correspond to 14TR and 16TR. * Statistically significant (P < 0.05)